A SARS-CoV-2 vaccine candidate based on highly effective live attenuated mumps virus expressing a six-proline-stabilized prefusion peak | Proceedings of the National Academy of Sciences pnas.org
A comparison of SARS-CoV-2 antibody profiles in elderly and young people News-Medical.Net
BNT162b2 vaccination induces moderate immunity against Omicron variant in children News-Medical.Net